Steven M. Greenberg, MD, PhD, FAHA, Chair; Wendy C. Ziai, MD, MPH, FAHA, Vice Chair;
Charlotte Cordonnier, MD, PhD; Dar Dowlatshahi, MD, PhD, FAHA; Brandon Francis, MD …

Acute spontaneous intracerebral haemorrhage is a life-threatening illness of global
importance, with a poor prognosis and few proven treatments. As a heterogeneous disease …

Background Early control of elevated blood pressure is the most promising treatment for
acute intracerebral haemorrhage. We aimed to establish whether implementing a goal …

Introduction: Spontaneous non-traumatic intracerebral hemorrhage (ICH) is most often
caused by small vessel diseases: deep perforator arteriopathy (hypertensive arteriopathy) or …

Intracerebral haemorrhage (ICH) accounts for half of the disability-adjusted life years lost
due to stroke worldwide. Care pathways for acute stroke result in the rapid identification of …

Objective Anticoagulation reversal, intensive blood pressure lowering, neurosurgery, and
access to critical care might all be beneficial in acute intracerebral hemorrhage (ICH). We …

Stroke is the second highest cause of death globally, with an increasing incidence in
developing countries. Intracerebral hemorrhage (ICH) accounts for 10–15% of all strokes …

Purpose: Intracerebral haemorrhage (ICH) is the most devastating form of stroke and a
major cause of disability. Clinical trials of individual therapies have failed to definitively …

The majority of people who suffer a stroke are older adults. The last two decades have
brought major progress in the diagnosis and management of stroke, which has led to …

The global burden of intracerebral haemorrhage (ICH) is enormous. Developing evidence-
based management strategies for ICH has been hampered by its diverse aetiology, high …